Statera Biopharma, Inc.
Statera Biopharma, Inc. (STAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STAB · as of Jun 9, 2026
Key Statistics
Explore Statera Biopharma, Inc. Data
stab stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
stab competitorsSTAB
BLMS
BTAX
BTTX
ERGO
EVLOStock Performance
Full HistoryAbout Statera Biopharma, Inc.
Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies. These novel treatments aim to address a range of serious conditions, including…
what is statera biopharma, inc. · stab stock overview · statera biopharma, inc. company profile · who is statera biopharma, inc. ceo · stab OTC · statera biopharma, inc. headquarters · statera biopharma, inc. business segments
About Stock Overview & Key Data
Statera Biopharma, Inc. (STAB) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 28, 2021. As of the latest trading session, STAB stock price is $0.00, with a market capitalization of $7,142. The stock has returned +0.00% over the past 12 months and -66.67% year-to-date.
In fiscal year 2021, Statera Biopharma, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Statera Biopharma, Inc. (STAB) stock price is $0.00. The stock is traded on OTC under the ticker symbol STAB. The 52-week range is $0.00 – $0.03.